Tolerability and efficacy of docetaxel in older men with metastatic castrate-resistant prostate cancer (mCRPC) in the TAX 327 trial - Concepedia

Concepedia

Publication | Open Access

Tolerability and efficacy of docetaxel in older men with metastatic castrate-resistant prostate cancer (mCRPC) in the TAX 327 trial

DOI Full Paper Access

78

Citations

16

References

2014

Year

Anne M. Horgan, Boštjan Šeruga, Gregory R. Pond, Shabbir M.H. Alibhai, Eitan Amir, Ronald de Wit, Mario A. Eisenberger, Ian F. Tannock

Journal of Geriatric Oncology

UrologyOncologyGenitourinary CancerTax 327PharmacotherapyOlder MenProstatic DiseaseMedicine

References

	Year	Citations

Page 1